HWP
DXCM icon

Highline Wealth Partners’s DexCom DXCM Stock Holding History

Highline Wealth Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9K Buy
162
+97
+149% +$6.46K ﹤0.01% 562
2026
Q1 		$4.08K Buy
65
+56
+622% +$3.9K ﹤0.01% 792
2025
Q4 		$597 Sell
9
-11
-55% -$711 ﹤0.01% 962
2025
Q3 		$1.35K Hold
20
– – ﹤0.01% 901
2025
Q2 		$1.75K Sell
20
-4
-17% -$314 ﹤0.01% 656
2025
Q1 		$1.64K Buy
24
+4
+20% +$326 ﹤0.01% 665
2024
Q4 		$1.55K Buy
20
+11
+122% +$814 ﹤0.01% 485
2024
Q3 		$603 Sell
9
-7
-44% -$575 ﹤0.01% 548
2024
Q2 		$1.81K Buy
16
+2
+14% +$253 ﹤0.01% 404
2024
Q1 		$1.94K Hold
14
– – ﹤0.01% 333
2023
Q4 		$1.74K Hold
14
– – ﹤0.01% 309
2023
Q3 		$1.31K Hold
14
– – ﹤0.01% 298
2023
Q2 		$1.8K Hold
14
– – ﹤0.01% 235
2023
Q1 		$1.63K Hold
14
– – ﹤0.01% 245
2022
Q4 		$1.58K Hold
14
– – ﹤0.01% 235
2022
Q3 		$1.13K Buy
+14
New +$1.19K ﹤0.01% 250

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Highline Wealth Partners's DXCM Position: Q2 2026 in Review

Highline Wealth Partners increased its DexCom (DXCM) stake by 149% in Q2 2026, buying an estimated $6.46K and bringing the position to 162 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #562.

Highline Wealth Partners first reported a position in DXCM in Q3 2022 and has held it in 16 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Highline Wealth Partners held 162 shares of DexCom worth $10.9K as of Q2 2026.
  • Highline Wealth Partners bought 97 DexCom shares in Q2 2026, an estimated $6.46K.
  • DexCom made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #562 holding.
  • Highline Wealth Partners first reported a position in DexCom in Q3 2022 and has held it in 16 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.